new announcement, page-25

While its positive for the approach & technology, commercially it would mean that people might think that Amgen has a significant first mover advantage over VLA and if they commercialize their product, unless ours is significantly better, then we will only ever be a bit player.

As such i think it will mostly serve to raise awareness and acceptance of the technology, but not much else for us/vla in the short term, imo.